Perfil
Scott A.
Young currently works at Flexion Therapeutics, Inc., as VP-Corporate Communications & Investor Relations from 2018 and Invivyd, Inc., as Head-Investor Relations from 2023.
Cargos activos de Scott A. Young
Empresas | Cargo | Inicio |
---|---|---|
FLEXION THERAPEUTICS, INC. | Investor Relations Contact | 01/11/2016 |
INVIVYD, INC. | Investor Relations Contact | 01/08/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
INVIVYD, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Flexion Therapeutics, Inc.
Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Scott A. Young